Screening Undiagnosed Afib
Advancing the Diagnosis of Atrial Fibrillation and Reducing the Risk of Strokes
Revival Research Insitute, equipped with years of experience in medical leadership, project management, and clinical operations, is committed to executing cardiovascular trials with proven effective strategies. Our dedicated staff and LICENSED physicians are determined to deliver quality medicine and healthcare to participants in our clinical trials.
Atrial Fibrillation (AF) is a common cardiac arrhythmia. According to a study, almost 700,000 Americans have undiagnosed AF. These people are at risk for AF-related strokes which are potentially preventable by appropriate treatment with oral anticoagulation (OAC). Thus, undiagnosed AF is a substantial public health issue.
Revival Research Institute is conducting a research study to detect Atrial Fibrillation in patients who have not been diagnosed with AF. The proposed study will provide data to show that screening for AF reduces stroke risk and provides a clinical benefit compared to usual care.
Join us by participating in our clinical trial and be a part of the life-changing development in cardiovascular care.
Participation Criteria For Atrial Fibrillation:
- Men and women at least 70 years of age or older.
- Comply with study procedures.
- Additional criteria may apply.
Our group of LICENSED and certified physicians will keep track of your progress throughout the study and address any concerns or queries you may have about the research trial. If you qualify and choose to join the study, you will receive all study-related care and study medication at no cost.
